The debate about how to protect humans from the H5N1 avian influenza continues. During the H1N1 swine flu pandemic in 2009, vaccines became available months after the virus had spread—and even then there was only enough for 20% of the world’s population. Now, talk is centering on immunizing people years in advance against a flu pandemic that has yet to happen—“pre-pandemic vaccination.” Keeping the idea in the concept stage is how to get governments to pay for a health emergency that hasn’t happened yet. Same goes for persuading the public to get a shot that could potentially cause mild fever, pain at the injection site and the occasional allergic reaction. “It’s got loads of common sense about it and it’s got loads of science behind it,” said David Salisbury, Britain’s director of immunization. “But it is a big step.”
Bird flu vaccine more than a shot in the dark (Reuters)
Comments
Special Features
2013 Outlook As we move into a transition year, check out LifeHealthPro's conjectures for the life, annuities, health and disability markets.
100 Best Sales & Marketing Ideas Whether you want ideas for referrals, generating leads or just listening to your clients better, we have the sales and marketing tips you need.
The Complete ELNY Saga For more than two decades, the Executive Life Insurance Company of New York (ELNY) has been bled for billions of dollars while languishing in a state-imposed purgatory.
Life Insurance A-Z This alphabetical-themed infographic will help your clients feel more comfortable discussing life insurance protection concepts.
2012 Advisor of the Year Through a very thorough nomination process we look to find a top producer who is a true cornerstone of a community.
Senior Survey 2011 In this special section, find out how seniors build their nest egg, make an estate plan, finance their health care and where they live.
